Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
440
datasets available to search
ShareScore release 0.9.0
Dataset results
440 results for “Dapagliflozin”
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
ClinicalTrials.gov study NCT03331289. IPD Sharing: YES. Countries: 1. Publications: 1.
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
ClinicalTrials.gov study NCT04792190. IPD Sharing: NO. Countries: 1. Publications: 42.
Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients
ClinicalTrials.gov study NCT05944016. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
ClinicalTrials.gov study NCT01195662. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02426541. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
ClinicalTrials.gov study NCT05788276. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00736879. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin
ClinicalTrials.gov study NCT00673231. IPD Sharing: Not stated. Countries: 13. Publications: 8.
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03660683. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients
ClinicalTrials.gov study NCT02279407. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
ClinicalTrials.gov study NCT02229396. IPD Sharing: Not stated. Countries: 6. Publications: 4.
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes an
ClinicalTrials.gov study NCT02547935. IPD Sharing: Not stated. Countries: 9. Publications: 3.
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
ClinicalTrials.gov study NCT02460978. IPD Sharing: Not stated. Countries: 13. Publications: 7.
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02413398. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT00680745. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT00859898. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT00972244. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
ClinicalTrials.gov study NCT03190694. IPD Sharing: UNDECIDED. Countries: 3. Publications: 2.
Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
ClinicalTrials.gov study NCT02682563. IPD Sharing: NO. Countries: 1. Publications: 7.
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
ClinicalTrials.gov study NCT03877224. IPD Sharing: YES. Countries: 12. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.